Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Heverin

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALSRobert McFarlane, Sarah Opie-Martin, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohortAlejandro Caravaca Puchades, Harry E McDonough, Ammar Al-Chalabi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALSHarry McDonough, Robert McFarlane, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 21, 2025
Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonizationEmmet Costello, Joke De Vocht, Emily Beswick, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant StudyRuben P A van Eijk, Daphne N Weemering, Sarah Opie-Martin, et al.
Ebiomedicine|October 11, 2025
Optimised machine learning for time-to-event prediction in healthcare applied to timing of gastrostomy in ALS: a multi-centre, retrospective model development and validation studyMarcel Weinreich, Harry McDonough, Mark Heverin, et al.
The Lancet. Neurology|March 31, 2018
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction modelHenk-Jan Westeneng, Thomas P A Debray, Anne E Visser, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics|February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Clinical trajectories of genetic variants in ALS: a European observational study within PRECISION-ALSRobert McFarlane, Sarah Opie-Martin, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Mapping the natural history of amyotrophic lateral sclerosis: time-to-event analysis of clinical milestones in the pan-European, population-based PRECISION-ALS cohortAlejandro Caravaca Puchades, Harry E McDonough, Ammar Al-Chalabi, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALSHarry McDonough, Robert McFarlane, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 21, 2025
Neuropsychological assessment practices in PRECISION-ALS: challenges and opportunities for harmonizationEmmet Costello, Joke De Vocht, Emily Beswick, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Natural history of the revised ALS functional rating scale and its association with survival: the PRECISION-ALS Extant StudyRuben P A van Eijk, Daphne N Weemering, Sarah Opie-Martin, et al.
Ebiomedicine|October 11, 2025
Optimised machine learning for time-to-event prediction in healthcare applied to timing of gastrostomy in ALS: a multi-centre, retrospective model development and validation studyMarcel Weinreich, Harry McDonough, Mark Heverin, et al.
The Lancet. Neurology|March 31, 2018
Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction modelHenk-Jan Westeneng, Thomas P A Debray, Anne E Visser, et al.
Nature Genetics|December 7, 2021
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Nature Genetics|February 1, 2022
Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biologyWouter van Rheenen, Rick A A van der Spek, Mark K Bakker, et al.
Pageof 9